🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06040697
Recruiting Observational

Formative Usability Assessment of Wireless Thermal Anisotropy Devices

NCT06040697 · tracked via the Priya Life Science USA tracker
Sponsor
Rhaeos, Inc.
Phase
Observational
Started
2023-09-29
Last updated
2025-05-15

Condition(s) studied

Hydrocephalus

Investigational drug(s) / intervention(s)

Thermal Anisotropy

Thermal Anisotropy: Usability assessment observation.

Study summary

Measurements of shunt flow will be performed non-invasively. This study will generate usability data via observed tasks and comprehension questions to enable future device design improvements.

Eligibility

Sex
ALL
Min age
5 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Existing ventricular CSF shunt with a region of intact skin overlying the shunt catheter appropriate in size for application of the study device 2. Signed informed consent by subject or a parent, legal guardian, health care agent, or surrogate decision maker (according to local statutes) 3. Subject or caregiver can clearly communicate and document information in English 4. Verbal assent by minors 12 years of age and older who can understand the study and communicate their decision 5. Subject is at least 5 years old but not more than 80 years old Exclusion Criteria: 1. Presence of an interfering open wound in the device application region 2. Subject-reported history of adverse skin reactions to adhesives

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Rhaeos, Inc. Chicago Illinois Recruiting

More Rhaeos, Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06040697 on ClinicalTrials.gov ↗ ← All trials in the USA